Meta Pixel

News and Announcements

The Art of Pitching: Navigating the Use of “Disruptive” and “Revolutionary”

  • Published October 10, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

In the dynamic world of startups and innovation, terms like “disruptive,” “revolutionary,” and “breakthrough” are often thrown around. But are these terms always accurate, or are they just buzzwords that sound impressive? Steve Torso, the CEO & Co-Founder of Wholesale Investor, delves into the nuances of these terms and their implications in the capital raising process.

YouTube player

The Desire to Stand Out

Every founder and innovator wants their product or service to be seen as unique, groundbreaking, and, yes, disruptive. They envision their offerings as game-changers that redefine industries, much like how electric vehicles are reshaping the automotive sector. However, the reality often differs from this vision.

The Pitfalls of Overclaiming

While it’s natural for founders to view their products as revolutionary, it’s crucial to ensure these claims are substantiated. Labeling a product as “disruptive” when it merely offers an alternative to existing solutions can be misleading. For instance, electric vehicles don’t just provide an alternative mode of transport; they challenge the very foundation of the petroleum industry, rendering traditional petrol stations obsolete.

Perception vs. Reality

Founders often see the vast potential of their products. They dream of being the next Elon Musk, revolutionising entire industries. However, from an investor’s perspective, terms like “world’s only” or “breakthrough” can be red flags. Investors often encounter multiple pitches claiming similar unique attributes. Thus, making unsubstantiated claims can lead to skepticism and missed opportunities.

Advice for Founders

Steve Torso advises founders to be cautious with their choice of words. While passion and belief in one’s product are essential, it’s equally crucial to present a realistic picture to potential investors. Avoid overusing terms like “disruptive” or “world’s only” unless they can be genuinely substantiated. Instead, focus on the tangible benefits, the actual market gap being addressed, and the real-world impact of the product or service.

Conclusion

In the competitive world of startups and capital raising, authenticity and clarity are paramount. While it’s tempting to label every innovation as “disruptive” or “revolutionary,” it’s essential to ensure these claims stand up to scrutiny. By presenting a balanced and realistic picture, founders can build trust with investors and pave the way for successful collaborations.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now